Global Health Industry Headlines: IPOs, Drug Breakthroughs, and Policy Shifts

Recent health news highlights include Grifols' U.S. biopharma business planning an IPO, Kodiak Sciences’ share surge after a successful study, and a bipartisan U.S. Senate deal to cap insulin prices at $35. Several companies face FDA challenges, fresh drug approvals are noted, and global policies impacting health are addressed.

Spanish drugmaker Grifols has decided to launch an initial public offering for its U.S. biopharma business, planning to float a minority stake while maintaining majority ownership.

Kodiak Sciences witnessed a significant boost in its share value after successfully trialing an eye drug targeting diabetic retinopathy.

In a notable legislative move, U.S. senators reached a bipartisan agreement to cap insulin prices at $35, seeking swift action before Senator Shaheen's retirement.

(With inputs from agencies.)